Status:
COMPLETED
Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Lead Sponsor:
Queen's University
Collaborating Sponsors:
AstraZeneca
Conditions:
Dyslipidemia
Acute Coronary Syndromes
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This is a 3-month, randomized, parallel-group study with 2 periods, comparing the efficacy and the safety of rosuvastatin 20 mg versus atorvastatin 80 mg in patients with an acute coronary syndrome (A...
Detailed Description
Patients with ACS (acute coronary syndrome) constitute a high-risk population with unstable coronary disease (CHD) that differs from stable CHD primarily in short term prognosis (prediction of outcome...
Eligibility Criteria
Inclusion
- Men or women who are between 18 and 75 years old
- Patients diagnosed with non ST elevation - acute coronary syndrome (NSTE-ACS)
- Patients with onset of clinical symptoms less than 24 hours prior to their admission for which a PCI is planned or anticipated.
Exclusion
- Patients with STEMI (ST elevation myocardial infarction-heart attack) and primary PCI planned within 24 hours of admission will not be included.
- Patients will not be allowed to have taken any cholesterol-lowering medications during 1 month prior to enrolment.
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00665834
Start Date
April 1 2006
End Date
September 1 2007
Last Update
March 29 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston General Hospital
Kingston, Ontario, Canada, K7L 2V7
2
Vascular Disease Prevention and Research Centre, Hotel Dieu Hospital
Kingston, Ontario, Canada, K7L 5G2